While this panel has grown in recent years, many experts believe additional biomarkers should also be incorporated as emerging data support targeted options in earlier disease settings. Expanding ...
The U.S. FDA assigned a target action date of April 8, 2026PRINCETON, N.J.--(BUSINESS WIRE)--$BMY #FDA--Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA ...
Lung cancer has traditionally been seen as a smoking-related disease, which has led people to believe it's a result of a person's own choices. But the reality of clinical practice is different: ...
Genes steadily associated with prognosis define conserved mitotic and immune programs that robustly predict cancer patient survival and therapeutic resistance across tumor types.
Arima Genomics, Inc ., a company leveraging whole-genome sequence and structure information to provide comprehensive cancer therapy selection insights, today announced new data to be presented at the ...
Alaska Air Group Inc. (NYSE:ALK) is among the 8 Best Airline Stocks to Buy Heading into 2026. The company and its subsidiaries operate airlines in three segments: Alaska Airlines, Hawaiian Airlines, ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
About Alaska Air Group Inc. Alaska Air Group, Inc. is a holding company, which engages in the provision of air transportation services. It operates through the following segments: Alaska Airlines, ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Opdivo (nivolumab), in combination with Yervoy (ipilimumab), is indicated for the treatment of adult and paediatric patients 12 years and older with unresectable or metastatic microsatellite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results